Table III.
Spearman's Correlation Coefficient of serum values VEGF and PEDF with immunostaining intensity percentage in prostatic diseases.
| Serum | ||
|---|---|---|
| Biopsy (%) | VEGF | PEDF |
| BPH | ||
| VEGF | 0.166 | – |
| PEDF | – | −0.198 |
| PCa | ||
| VEGF | 0.661b | – |
| PEDF | – | 0.661b |
| AdGS6-7 | ||
| VEGF | 0.580a | – |
| PEDF | – | 0.344 |
| AdGS8-10 | ||
| VEGF | 0.611 | – |
| PEDF | – | 0.881b |
a
P≤0.05
b
P<0.01. pCA, prostate cancer; BPH, benign prostatic hyperplasia; AdGSC, adenocarcinoma with Gleason score; VEGF, vascular endothelial growth factor; PEDF, pigment epithelium-derived factor.